B. Linot

625 total citations
9 papers, 86 citations indexed

About

B. Linot is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, B. Linot has authored 9 papers receiving a total of 86 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in B. Linot's work include Colorectal Cancer Treatments and Studies (3 papers), Oral health in cancer treatment (2 papers) and Brain Metastases and Treatment (2 papers). B. Linot is often cited by papers focused on Colorectal Cancer Treatments and Studies (3 papers), Oral health in cancer treatment (2 papers) and Brain Metastases and Treatment (2 papers). B. Linot collaborates with scholars based in France, United States and Belgium. B. Linot's co-authors include Olivier Capitain, Paule Augereau, R. Breheret, Laurent Laccourreye, N. Paillocher, Romuald Wernert, G. Lorimier, Véronique Verrièle, Denis Dupoiron and A. Hamy and has published in prestigious journals such as Annals of Oncology, European Journal of Cancer and Cancers.

In The Last Decade

B. Linot

8 papers receiving 86 citations

Peers

B. Linot

SURGE

ONCOL

PRM

EM

RM

Alexandra Brandt Netherlands

Fernando Mendoza‐Moreno Spain

G. Sen United Kingdom

Inmaculada Lasa Spain

Tarek Boussaha France

K. Taku Japan

Patrizia Marsanic Italy

Simona Papi Italy

Luís Alberto Schlittler Brazil

Giuseppe Cucinella Italy

Alexandra Brandt Netherlands

B. Linot

70 ×1.6

SURGE

82 ×1.9

ONCOL

23 ×0.8

PRM

36 ×1.6

EM

27 ×2.3

RM

Citations per year, relative to B. Linot B. Linot (= 1×) peers Alexandra Brandt

Countries citing papers authored by B. Linot

Since Specialization

Citations

This map shows the geographic impact of B. Linot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Linot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Linot more than expected).

Fields of papers citing papers by B. Linot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Linot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Linot. The network helps show where B. Linot may publish in the future.

Co-authorship network of co-authors of B. Linot

This figure shows the co-authorship network connecting the top 25 collaborators of B. Linot. A scholar is included among the top collaborators of B. Linot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Linot. B. Linot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Malicot, Karine Le, et al.. (2025). 727MO FOLFOX plus PANITUMUMAB (Pmab) according to a “stop-and-go” strategy in first-line in patients (pts) with non-mutated RAS/BRAF metastatic colorectal cancer (mCRC): Results of the FFCD 1605 – OPTIPRIME phase II trial. Annals of Oncology. 36. S476–S476.

2.

Mazard, Thibault, Laure Cayrefourcq, Hélène Senellart, et al.. (2021). Clinical Relevance of Viable Circulating Tumor Cells in Patients with Metastatic Colorectal Cancer: The COLOSPOT Prospective Study. Cancers. 13(12). 2966–2966. 13 indexed citations

3.

Castanie, H., et al.. (2019). Skin Metastases from Ovarian Carcinoma. 4(1). 1 indexed citations

4.

Lorimier, G., B. Linot, N. Paillocher, et al.. (2016). Curative cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis and synchronous resectable liver metastases arising from colorectal cancer. European Journal of Surgical Oncology. 43(1). 150–158. 30 indexed citations

5.

Linot, B., et al.. (2016). Exclusive concurrent radiochemotherapy for advanced head and neck cancers with ‘fractionated’ 5-fluorouracil and cisplatin. Anti-Cancer Drugs. 28(2). 213–221. 1 indexed citations

6.

Linot, B., et al.. (2015). Feasibility and safety of dose-dense modified docetaxel–cisplatin or carboplatin and 5-fluorouracil regimen (mTPF) in locally advanced or metastatic head and neck cancers: a retrospective monocentric study. International Journal of Clinical Oncology. 20(6). 1086–1092. 5 indexed citations

7.

Paule, Bernard, Jennifer Wallet, David Tougeron, et al.. (2015). 2095 Survival benefit, safety, and prognostic factors for outcome with Regorafenib (RE) in patients (pts) with pretreated metastatic colorectal cancer (mCRC). Main analyses of the REBECCA study. European Journal of Cancer. 51. S360–S360. 1 indexed citations

8.

Linot, B., Mario Campone, Paule Augereau, et al.. (2014). Use of liposomal doxorubicin–cyclophosphamide combination in breast cancer patients with brain metastases: a monocentric retrospective study. Journal of Neuro-Oncology. 117(2). 253–259. 15 indexed citations

9.

Linot, B., Paule Augereau, R. Breheret, Laurent Laccourreye, & Olivier Capitain. (2014). Efficacy and safety of early G-CSF administration in patients with head and neck cancer treated by docetaxel-cisplatin and 5-fluorouracil (DCF protocol): a retrospective study. Supportive Care in Cancer. 22(10). 2831–2837. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact